MUC1 and breast neoplasm: Redirecting T lymphocytes against MUC1-positive breast cancer cells by CAR technology was first developed and characterized by Scott Wilkie et al. and indicated that the MUC1-targeting CAR T cells efficiently eliminate breast tumors [4].